SeqLL (SQL) Stock
Company Profile
Price: $6.60
Market Cap: $185.31M
Exchange: NASDAQ
CEO: Mr. Daniel Robert Jones
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Employees: -0.00B
Headquarters: Billerica, MA
Website: SeqLL
Business Summary
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.
SeqLL Chart
SeqLL News
SeqLL Defers Proposed Cash and Stock Distributions to Stockholders in Connection With Proposed Acquisition
BILLERICA, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (Nasdaq: SQL, SQLLW), today announced the decision of its Board of Directors to cancel the special cash dividend and stock dividend that it intended to make to its common stockholders in connection with, and subject to, the consummation of its planned acquisition of Lyneer Investments LLC (“Lyneer”) and the disposition of its current business operations.
-
globenewswire.com
2023-10-30
SeqLL Announces Cash and Stock Dividend Record Date
BILLERICA, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (Nasdaq: SQL, SQLLW), announced today that its board of directors has set September 26, 2023 as the record date for its special stock dividend and cash dividend to be made to the holders of its common stock pursuant to the terms of the Agreement and Plan of Reorganization dated as of May 29, 2023, as amended (the “Merger Agreement”), by and among the Company, SeqLL Merger LLC, Atlantic Acquisition Corp., Atlantic Merger LLC, Lyneer Investments, LLC, IDC Technologies, Inc. and Lyneer Management Holdings LLC. The dividend distribution of shares of common stock of the Company and the cash dividend will be made to all SeqLL common stockholders of record as of the close of business on September 26, 2023 (the "Record Date"). The cash and stock dividends, which are contingent upon, and subject to, the consummation of the transactions contemplated by the Merger Agreement, are expected to be completed on or about October 2, 2023 (the "distribution date"), subject to certain conditions.
-
globenewswire.com
2023-09-15
SeqLL to Conduct 1-for-40 Reverse Stock Split
BILLERICA, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (Nasdaq: SQL, SQLLW), a technology company providing life sciences instrumentation and research services, today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-40. The reverse stock split will become effective at 11:59 p.m. Eastern Time, on August 30, 2023. The Company's common stock will begin trading on a post-split basis at the market open on August 31, 2023, under the Company's existing trading symbol "SQL". The reverse stock split is part of the Company's plan to regain compliance with the Minimum Bid Price Requirement of $1.00 per share required to maintain continued listing on The Nasdaq Capital Market, among other benefits.
-
globenewswire.com
2023-08-30
Why Is SeqLL (SQL) Stock Up 43% Today?
SeqLL (NASDAQ: SQL ) stock is on the rise Monday with heavy trading despite a lack of news from the molecule sequencing technology company. Getting into that trading, some 1.7 million shares of SQL stock have changed hands as of this writing.
-
investorplace.com
2023-05-22
SeqLL stock rockets on heavy volume again, in wake of 2-year development pact with FBI
Shares of SeqLL Inc. SQL, -38.69% more than doubled on heavy volume ahead of Friday's open, in the wake of the genetic sequencing company's announcement earlier in the week about an product development agreement with the Federal Bureau of Investigation. The stock skyrocketed 128.6% on volume of 16.1 million shares premarket, enough to make it the biggest gainer and most active stock listed on major U.S. exchanges.
-
marketwatch.com
2023-02-10
Why Is SeqLL (SQL) Stock Up 256% Today?
SeqLL (NASDAQ: SQL ) stock is seeing massive gains on Tuesday after signing a new contract with a government agency. Specifically, the company has signed a two-year Cooperative Research and Development Agreement (CRADA) with the Federal Bureau of Investigation (FBI).
-
investorplace.com
2023-02-07
SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference
BILLERICA, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services for collaborative partnerships, today announced that Daniel Jones, CEO of SeqLL will present a corporate overview and be available for virtual 1x1 meetings at the upcoming H.C. Wainwright 24th Annual Global Conference taking place from September 12-14, 2022.
-
globenewswire.com
2022-09-06
SeqLL Earnings
This section highlight's SeqLL's earnings, including earnings call transcripts, earnings surprises, and key dates.
SeqLL Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|
SeqLL Earnings Dates
When is the next earnings date for SQL?
Date:Status: Unconfirmed
Time of Day:
Estimated EPS: $-
When was the last earnings date for SQL?
Date: 2024-06-29Fiscal Date Ending: 2024-06-30
EPS: $-1.96
Estimated EPS: $-
Revenue: $104.64M
Estimated Revenue: $-
Financial Statements
This section provides financial statements for SeqLLincluding income statements, balance sheets, and cash flow statements, both annually and quarterly.
Annual Income Statement
| Breakdown | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Revenue | $779.07K | $160.48K | $50.59K | $48.02K | $1.18K |
| Cost of Revenue | $674.28K | $219.76K | $170.80K | $57.69K | $-0.00B |
| Gross Profit | $104.79K | $-59.28K | $-120.22K | $-9.67K | $-0.00B |
| Gross Profit Ratio | 13.45% | -36.94% | -237.64% | -20.13% | 41.38% |
| Research and Development Expenses | $1.04M | $1.25M | $330.98K | $530.08K | $1.57M |
| General and Administrative Expenses | $1.47M | $1.36M | $777.43K | $2.17M | $2.51M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $1.47M | $1.36M | $777.43K | $2.17M | $2.51M |
| Other Expenses | $182.44K | $-372.65K | $-278.91K | $-161.97K | $-77.48K |
| Operating Expenses | $2.51M | $2.23M | $829.51K | $2.54M | $4.00M |
| Cost and Expenses | $3.18M | $2.45M | $1.00M | $2.60M | $4.00M |
| Interest Income | $- | $182.25K | $287.20K | $171.83K | $44.88K |
| Interest Expense | $486.73K | $182.25K | $287.20K | $208.29K | $90.75K |
| Depreciation and Amortization | $63.64K | $121.53K | $300.32K | $80.67K | $132.82K |
| EBITDA | $-1.90M | $-2.17M | $-649.40K | $-2.47M | $-3.86M |
| EBITDA Ratio | -243.72% | -1352.05% | -1283.70% | -5139.32% | -328320.48% |
| Operating Income | $-2.40M | $-2.29M | $-949.72K | $-2.55M | $-4.00M |
| Operating Income Ratio | -308.23% | -1427.78% | -1877.37% | -5307.32% | -339604.76% |
| Total Other Income Expenses Net | $-256.43K | $-182.25K | $-95.63K | $-1.15M | $-97.69K |
| Income Before Tax | $-2.89M | $-2.47M | $-1.05M | $-3.70M | $-4.09M |
| Income Before Tax Ratio | -370.70% | -1541.34% | -2066.41% | -7712.37% | -347904.25% |
| Income Tax Expense | $486.73K | $182.25K | $478.76K | $202.52K | $97.69K |
| Net Income | $-2.89M | $-2.66M | $-1.52M | $-3.91M | $-4.19M |
| Net Income Ratio | -370.70% | -1654.91% | -3012.80% | -8134.10% | -356203.74% |
| EPS | $-23.75 | $-21.84 | $-12.53 | $-21.65 | $-14.11 |
| EPS Diluted | $-23.75 | $-21.84 | $-12.53 | $-21.65 | $-14.11 |
| Weighted Average Shares Outstanding | 121.62K | 121.62K | 121.62K | 180.40K | 297.16K |
| Weighted Average Shares Outstanding Diluted | 121.62K | 121.62K | 121.62K | 180.40K | 297.16K |
| SEC Filing | Source | Source | Source | Source | Source |
Quarterly Income Statement
| Breakdown | 2018-06-30 | 2019-03-31 | 2019-06-30 | 2020-03-31 | 2020-06-30 | 2020-09-30 | 2020-12-31 | 2021-03-31 | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2024-03-31 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $91.55K | $106.86K | $150.26K | $41.84K | $- | $- | $8.75K | $26.10K | $5.98K | $15.94K | $- | $- | $1.18K | $- | $78.66K | $- | $- | $- | $- | $104.64M |
| Cost of Revenue | $331.29K | $16.45K | $139.63K | $83.82K | $13.18K | $- | $73.80K | $27.95K | $12.79K | $4.05K | $12.90K | $- | $-0.00B | $- | $-0.00B | $- | $- | $- | $- | $93.15M |
| Gross Profit | $-239.74K | $90.41K | $10.63K | $-41.98K | $-13.18K | $- | $-65.05K | $-1.85K | $-6.81K | $11.89K | $-12.90K | $- | $-0.00B | $- | $77.97K | $- | $- | $- | $- | $11.49M |
| Gross Profit Ratio | -261.85% | 84.61% | 7.08% | -100.34% | 0.00% | 0.00% | -743.46% | -7.09% | -113.77% | 74.59% | 0.00% | 0.00% | 41.38% | 0.00% | 99.12% | 0.00% | 0.00% | 0.00% | 0.00% | 10.98% |
| Research and Development Expenses | $119.38K | $393.39K | $176.40K | $240.06K | $8.88K | $30.37K | $51.67K | $17.95K | $24.46K | $90.66K | $397.00K | $334.67K | $365.85K | $428.77K | $438.98K | $776.72K | $581.72K | $411.33K | $316.26K | $- |
| General and Administrative Expenses | $346.62K | $332.56K | $335.89K | $236.03K | $298.83K | $171.48K | $71.10K | $387.39K | $425.23K | $360.94K | $997.29K | $584.87K | $625.74K | $489.73K | $806.51K | $981.11K | $862.69K | $877.61K | $749.56K | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $346.62K | $332.56K | $335.89K | $236.03K | $298.83K | $171.48K | $71.10K | $387.39K | $425.23K | $360.94K | $997.29K | $584.87K | $625.74K | $489.73K | $806.51K | $981.11K | $862.69K | $877.61K | $749.56K | $18.55M |
| Other Expenses | $- | $- | $- | $1.02K | $190.55K | $- | $- | $- | $187.91K | $-193.68K | $- | $2.73K | $- | $- | $77.48K | $- | $- | $- | $- | $- |
| Operating Expenses | $466.01K | $725.95K | $512.29K | $439.11K | $260.17K | $116.28K | $13.95K | $370.71K | $392.28K | $416.64K | $1.36M | $872.06K | $961.58K | $918.50K | $1.25M | $1.76M | $1.44M | $1.29M | $1.07M | $18.55M |
| Cost and Expenses | $797.30K | $742.40K | $651.92K | $522.93K | $273.35K | $116.28K | $87.76K | $398.66K | $405.07K | $420.69K | $1.37M | $872.06K | $962.27K | $918.50K | $1.25M | $1.76M | $1.44M | $1.29M | $1.07M | $111.70M |
| Interest Income | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $5.75K | $9.98K | $26.42K | $39.46K | $44.29K | $- | $- | $- |
| Interest Expense | $- | $- | $- | $66.80K | $72.36K | $72.77K | $75.27K | $107.80K | $41.13K | $41.07K | $18.30K | $16.81K | $39.57K | $17.19K | $17.19K | $16.81K | $22.85K | $22.34K | $39.82K | $4.00M |
| Depreciation and Amortization | $15.00K | $14.71K | $14.71K | $30.21K | $27.53K | $25.85K | $25.16K | $21.46K | $21.54K | $21.54K | $21.90K | $19.44K | $23.02K | $34.71K | $55.64K | $30.25K | $41.33K | $41.33K | $- | $1.25M |
| EBITDA | $-690.75K | $-620.83K | $-486.95K | $-449.86K | $-55.27K | $-90.42K | $-53.85K | $-351.10K | $-189.63K | $-576.89K | $-1.35M | $-852.62K | $-938.08K | $-883.79K | $-1.19M | $-1.73M | $-1.40M | $-1.25M | $-1.10M | $-66.88M |
| EBITDA Ratio | -754.47% | -581.00% | -324.07% | -1075.24% | 0.00% | 0.00% | -615.38% | -1345.23% | -3169.00% | -3619.82% | 0.00% | 0.00% | -79700.59% | 0.00% | -1512.67% | 0.00% | 0.00% | 0.00% | 0.00% | -63.92% |
| Operating Income | $-705.75K | $-635.54K | $-501.66K | $-481.09K | $-273.35K | $-116.28K | $-79.01K | $-372.56K | $-399.09K | $-404.75K | $-1.37M | $-872.06K | $-961.10K | $-918.50K | $-1.25M | $-1.76M | $-1.44M | $-1.29M | $-1.10M | $-8.31M |
| Operating Income Ratio | -770.85% | -594.77% | -333.86% | -1149.89% | 0.00% | 0.00% | -902.94% | -1427.43% | -6669.30% | -2539.69% | 0.00% | 0.00% | -81656.50% | 0.00% | -1583.41% | 0.00% | 0.00% | 0.00% | 0.00% | -7.94% |
| Total Other Income Expenses Net | $-71.60K | $-28.44K | $-42.61K | $1.02K | $190.55K | $-72.77K | $-75.27K | $-934.26K | $187.91K | $-193.68K | $-6.62K | $-49.09K | $-33.82K | $-7.45K | $9.48K | $39.46K | $67.14K | $43.61K | $- | $-63.82M |
| Income Before Tax | $-777.35K | $-663.98K | $-544.27K | $-546.87K | $-155.16K | $-189.04K | $-154.28K | $-1.41M | $-252.30K | $-639.50K | $-1.40M | $-937.95K | $-994.91K | $-925.95K | $-1.24M | $-1.72M | $-1.40M | $-1.27M | $-1.10M | $-72.13M |
| Income Before Tax Ratio | -849.06% | -621.39% | -362.22% | -1307.12% | 0.00% | 0.00% | -1763.17% | -5419.99% | -4216.29% | -4012.67% | 0.00% | 0.00% | -84529.74% | 0.00% | -1571.36% | 0.00% | 0.00% | 0.00% | 0.00% | -68.94% |
| Income Tax Expense | $- | $- | $- | $67.81K | $262.91K | $- | $- | $107.80K | $229.04K | $-152.62K | $18.30K | $19.53K | $5.75K | $7.45K | $-828.26K | $-56.27K | $22.85K | $22.34K | $- | $-17.22M |
| Net Income | $-777.35K | $-663.98K | $-544.27K | $-546.87K | $-155.16K | $-189.04K | $-154.28K | $-1.41M | $-252.30K | $-639.50K | $-1.40M | $-937.95K | $-994.91K | $-933.40K | $-407.75K | $-1.66M | $-1.40M | $-1.27M | $-1.10M | $-54.91M |
| Net Income Ratio | -849.06% | -621.39% | -362.22% | -1307.12% | 0.00% | 0.00% | -1763.17% | -5419.99% | -4216.29% | -4012.67% | 0.00% | 0.00% | -84529.74% | 0.00% | -518.38% | 0.00% | 0.00% | 0.00% | 0.00% | -52.48% |
| EPS | $-2.66 | $-2.27 | $-1.86 | $-1.87 | $-0.01 | $-0.65 | $-0.01 | $-4.84 | $-0.92 | $-3.57 | $-0.12 | $-3.16 | $-3.35 | $-3.14 | $-1.37 | $-5.16 | $-4.03 | $-3.33 | $-2.87 | $-1.96 |
| EPS Diluted | $-2.66 | $-2.27 | $-1.86 | $-1.87 | $-0.01 | $-0.65 | $-0.01 | $-4.84 | $-0.92 | $-3.57 | $-0.12 | $-3.16 | $-3.35 | $-3.14 | $-1.37 | $-5.16 | $-4.03 | $-3.33 | $-2.87 | $-1.96 |
| Weighted Average Shares Outstanding | 292.43K | 292.43K | 292.43K | 292.43K | 11.70M | 292.43K | 11.70M | 292.43K | 273.83K | 179.28K | 11.89M | 297.16K | 297.16K | 297.16K | 297.16K | 322.16K | 347.16K | 380.65K | 382.15K | 28.08M |
| Weighted Average Shares Outstanding Diluted | 292.43K | 292.43K | 292.43K | 292.43K | 11.70M | 292.43K | 11.70M | 292.43K | 273.83K | 179.28K | 11.89M | 297.16K | 297.16K | 297.16K | 297.16K | 322.16K | 347.16K | 380.65K | 382.15K | 28.08M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $5.86K | $- | $4.02M | $2.18M | $2.69T |
| Short Term Investments | $- | $- | $5.93M | $4.04M | $- |
| Cash and Short Term Investments | $5.86K | $-108.81K | $9.95M | $6.22M | $2.69T |
| Net Receivables | $135.67K | $139.53K | $65.68K | $81.21K | $2.72B |
| Inventory | $284.26K | $203.01K | $224.16K | $165.85K | $- |
| Other Current Assets | $2.35K | $108.81K | $186.06K | $-0.00B | $32.93B |
| Total Current Assets | $428.14K | $342.54K | $10.42M | $6.64M | $2.73T |
| Property Plant Equipment Net | $446.00K | $337.24K | $265.27K | $1.66M | $1.62T |
| Goodwill | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $- | $- | $-4.03M | $- |
| Tax Assets | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $14.26K | $14.26K | $50.49K | $4.15M | $83.01B |
| Total Non-Current Assets | $460.26K | $351.50K | $315.75K | $1.78M | $1.71T |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $888.40K | $694.04K | $10.74M | $8.41M | $4.44T |
| Account Payables | $897.66K | $861.84K | $871.36K | $622.44K | $522.94B |
| Short Term Debt | $28.00K | $26.00K | $1.38M | $110.11K | $257.97B |
| Tax Payables | $- | $- | $- | $- | $- |
| Deferred Revenue | $25.00K | $- | $- | $- | $- |
| Other Current Liabilities | $271.06K | $123.64K | $311.40K | $495.46K | $1.75T |
| Total Current Liabilities | $1.22M | $1.01M | $2.56M | $1.23M | $2.53T |
| Long Term Debt | $2.50M | $3.54M | $- | $2.82M | $1.30T |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $-2.50M | $-3.54M | $- | $- | $- |
| Total Non-Current Liabilities | $2.50M | $3.54M | $- | $2.82M | $1.30T |
| Other Liabilities | $- | $- | $- | $-0.00B | $- |
| Total Liabilities | $3.72M | $4.55M | $2.56M | $4.05M | $3.83T |
| Preferred Stock | $-0.00B | $-0.00B | $- | $- | $- |
| Common Stock | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $4.00M |
| Retained Earnings | $-9.66M | $-10.71M | $-14.41M | $-18.51M | $-24.14T |
| Accumulated Other Comprehensive Income Loss | $- | $- | $- | $22.45K | $- |
| Other Total Stockholders Equity | $6.84M | $6.86M | $22.60M | $22.85M | $24.74T |
| Total Stockholders Equity | $-2.83M | $-3.85M | $8.18M | $4.37M | $607.74B |
| Total Equity | $-2.83M | $-3.85M | $8.18M | $4.37M | $607.74B |
| Total Liabilities and Stockholders Equity | $888.40K | $694.04K | $10.74M | $8.41M | $4.44T |
| Minority Interest | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $888.40K | $694.04K | $10.74M | $8.41M | $4.44T |
| Total Investments | $- | $- | $5.93M | $4.04K | $- |
| Total Debt | $2.52M | $3.56M | $1.38M | $2.93M | $1.56T |
| Net Debt | $2.52M | $3.56M | $-2.64M | $748.93K | $-1.14T |
Quarterly Balance Sheet
| Breakdown | 2019-03-31 | 2019-06-30 | 2020-12-31 | 2021-03-31 | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $52.18K | $55.02K | $- | $9.10K | $63.34K | $11.31M | $4.02M | $8.86M | $7.85M | $4.45M | $2.18M | $5.04M | $4.79M | $3.73M | $2.69T | $1.69M | $439.48K |
| Short Term Investments | $- | $- | $- | $- | $- | $- | $5.93M | $- | $- | $2.50M | $4.04M | $1.53M | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $52.18K | $55.02K | $- | $9.10K | $63.34K | $11.31M | $9.95M | $8.86M | $7.85M | $6.95M | $6.22M | $6.58M | $4.79M | $3.73M | $2.69T | $1.69M | $439.48K |
| Net Receivables | $218.55K | $228.19K | $139.53K | $80.67K | $30.71K | $65.70K | $65.68K | $155.19K | $108.88K | $89.51K | $81.21K | $2.72K | $2.72K | $2.72K | $2.72B | $2.72K | $58.38M |
| Inventory | $699.07K | $777.40K | $203.01K | $198.50K | $198.26K | $208.72K | $224.16K | $228.53K | $246.74K | $246.90K | $165.85K | $- | $- | $- | $- | $- | $- |
| Other Current Assets | $1.62K | $1.30K | $- | $- | $- | $270.15K | $186.06K | $123.12K | $39.10K | $222.83K | $171.86K | $120.90K | $32.33K | $- | $32.93B | $33.60K | $13.85M |
| Total Current Assets | $971.42K | $1.06M | $342.54K | $288.27K | $292.31K | $11.85M | $10.42M | $9.37M | $8.25M | $7.51M | $6.64M | $6.70M | $4.82M | $3.73M | $2.73T | $1.73M | $72.67M |
| Property Plant Equipment Net | $111.62K | $96.91K | $337.24K | $321.04K | $299.49K | $277.95K | $265.27K | $1.71M | $1.68M | $1.71M | $1.66M | $1.66M | $1.77M | $1.70M | $1.62T | $1.55M | $3.07M |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $33.79M |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $33.79M |
| Long Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $23.79M |
| Other Non-Current Assets | $24.73K | $16.99K | $14.26K | $14.26K | $14.26K | $14.26K | $50.49K | $111.25K | $171.25K | $127.76K | $118.95K | $111.10K | $78.39K | $79.33K | $83.01B | $81.22K | $850.66K |
| Total Non-Current Assets | $136.35K | $113.89K | $351.50K | $335.30K | $313.75K | $292.21K | $315.75K | $1.82M | $1.85M | $1.84M | $1.78M | $1.77M | $1.85M | $1.78M | $1.71T | $1.63M | $61.51M |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $1.11M | $1.18M | $694.04K | $623.57K | $606.07K | $12.14M | $10.74M | $11.19M | $10.10M | $9.35M | $8.41M | $8.47M | $6.68M | $5.51M | $4.44T | $3.35M | $134.18M |
| Account Payables | $548.07K | $598.18K | $861.84K | $936.52K | $1.09M | $836.15K | $871.36K | $624.45K | $500.40K | $583.57K | $622.44K | $886.12K | $381.84K | $405.72K | $522.94B | $497.44K | $433.66K |
| Short Term Debt | $14.00K | $20.00K | $26.00K | $26.00K | $26.00K | $- | $1.38M | $1.40M | $47.05K | $83.14K | $110.11K | $137.48K | $220.29K | $250.72K | $257.97B | $265.39K | $36.54M |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $17.29K | $12.97K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Current Liabilities | $274.56K | $314.01K | $123.64K | $207.83K | $191.15K | $197.84K | $311.40K | $327.42K | $287.69K | $304.10K | $495.46K | $448.49K | $354.57K | $358.00K | $1.75T | $1.79M | $31.45M |
| Total Current Liabilities | $716.64K | $788.15K | $1.01M | $1.17M | $1.31M | $1.03M | $2.56M | $2.35M | $835.14K | $970.82K | $1.23M | $1.47M | $956.71K | $1.01M | $2.53T | $2.55M | $68.43M |
| Long Term Debt | $1.44M | $1.97M | $3.54M | $3.79M | $4.82M | $1.65M | $- | $1.53M | $2.89M | $2.87M | $2.82M | $2.77M | $2.81M | $2.74M | $1.30T | $1.23M | $42.76M |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $- | $- | $- | $934.26K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Non-Current Liabilities | $1.44M | $1.97M | $3.54M | $4.72M | $4.82M | $1.65M | $- | $1.53M | $2.89M | $2.87M | $2.82M | $2.77M | $2.81M | $2.74M | $1.30T | $1.23M | $42.76M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $2.15M | $2.76M | $4.55M | $5.89M | $6.12M | $2.68M | $2.56M | $3.89M | $3.72M | $3.84M | $4.05M | $4.24M | $3.76M | $3.75M | $3.83T | $3.78M | $111.19M |
| Preferred Stock | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $-0.00B | $4.00M | $-0.00B | $-0.00B |
| Retained Earnings | $-7.86M | $-8.40M | $-10.71M | $-12.12M | $-12.38M | $-13.02M | $-14.41M | $-15.35M | $-16.35M | $-17.27M | $-18.51M | $-20.23M | $-21.63M | $-22.89M | $-24.14T | $-25.23M | $-59.78M |
| Accumulated Other Comprehensive Income Loss | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $22.45K | $17.94K | $- | $- | $- | $- | $- |
| Other Total Stockholders Equity | $6.81M | $6.82M | $6.86M | $6.86M | $6.86M | $22.48M | $22.60M | $22.65M | $22.72M | $22.79M | $22.85M | $24.43M | $24.54M | $24.65M | $24.74T | $24.81M | $82.77M |
| Total Stockholders Equity | $-1.04M | $-1.58M | $-3.85M | $-5.27M | $-5.52M | $9.46M | $8.18M | $7.30M | $6.37M | $5.51M | $4.37M | $4.23M | $2.91M | $1.75M | $607.74B | $-422.18K | $22.99M |
| Total Equity | $-1.04M | $-1.58M | $-3.85M | $-5.27M | $-5.52M | $9.46M | $8.18M | $7.30M | $6.37M | $5.51M | $4.37M | $4.23M | $2.91M | $1.75M | $607.74B | $-422.18K | $22.99M |
| Total Liabilities and Stockholders Equity | $1.11M | $1.18M | $694.04K | $623.57K | $606.07K | $12.14M | $10.74M | $11.19M | $10.10M | $9.35M | $8.41M | $8.47M | $6.68M | $5.51M | $4.44T | $3.35M | $134.18M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $1.11M | $1.18M | $694.04K | $623.57K | $606.07K | $12.14M | $10.74M | $11.19M | $10.10M | $9.35M | $8.41M | $8.47M | $6.68M | $5.51M | $4.44T | $3.35M | $134.18M |
| Total Investments | $- | $- | $- | $- | $- | $- | $5.93M | $- | $- | $2.50M | $4.04M | $1.53M | $- | $- | $- | $- | $- |
| Total Debt | $1.45M | $1.99M | $3.56M | $3.81M | $4.84M | $1.65M | $1.38M | $2.94M | $2.93M | $2.95M | $2.93M | $2.91M | $3.03M | $2.99M | $1.56T | $1.49M | $79.31M |
| Net Debt | $1.40M | $1.94M | $3.56M | $3.80M | $4.78M | $-9.66M | $-2.64M | $-5.92M | $-4.92M | $-1.50M | $748.93K | $-2.14M | $-1.76M | $-735.89K | $-1.14T | $-195.47K | $78.87M |
Annual Cash Flow Statement
| Breakdown | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|
| Net Income | $-2.47M | $-1.05M | $-3.70M | $-4.09M | $- |
| Depreciation and Amortization | $121.53K | $108.76K | $86.44K | $87.94K | $- |
| Deferred Income Tax | $- | $- | $977.34K | $- | $- |
| Stock Based Compensation | $30.94K | $20.21K | $333.98K | $256.90K | $- |
| Change in Working Capital | $553.50K | $-128.50K | $119.96K | $-155.38K | $- |
| Accounts Receivables | $85.05K | $23.99K | $- | $9.50K | $- |
| Inventory | $-4.96K | $81.25K | $-21.14K | $-20.71K | $- |
| Accounts Payables | $446.13K | $-35.82K | $9.52K | $-248.93K | $- |
| Other Working Capital | $27.28K | $-197.91K | $131.58K | $104.75K | $- |
| Other Non Cash Items | $182.25K | $286.97K | $195.96K | $242.81K | $- |
| Net Cash Provided by Operating Activities | $-1.59M | $-757.91K | $-1.99M | $-3.66M | $- |
| Investments in Property Plant and Equipment | $- | $- | $-14.47K | $-40.02K | $- |
| Acquisitions Net | $- | $- | $- | $-1.83T | $- |
| Purchases of Investments | $- | $- | $-5.98M | $-4.01M | $- |
| Sales Maturities of Investments | $- | $- | $- | $5.88M | $- |
| Other Investing Activities | $- | $- | $-5.98M | $1.83T | $1.83T |
| Net Cash Used for Investing Activities | $- | $- | $-5.99M | $1.83M | $1.83T |
| Debt Repayment | $-14.50K | $-35.00K | $-577.89K | $- | $- |
| Common Stock Issued | $- | $- | $13.81M | $- | $- |
| Common Stock Repurchased | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $1.54M | $787.05K | $-1.24M | $12.00T | $1.46T |
| Net Cash Used Provided by Financing Activities | $1.53M | $752.05K | $12.00M | $12.00T | $1.46T |
| Effect of Forex Changes on Cash | $- | $- | $- | $-12.00T | $- |
| Net Change in Cash | $-58.83K | $-5.86K | $4.02M | $-1.83M | $3.29T |
| Cash at End of Period | $5.86K | $- | $4.02M | $2.18M | $1.83T |
| Cash at Beginning of Period | $64.69K | $5.86K | $- | $4.02M | $-1.46T |
| Operating Cash Flow | $-1.59M | $-757.91K | $-1.99M | $-3.66M | $- |
| Capital Expenditure | $- | $- | $-14.47K | $-40.02K | $- |
| Free Cash Flow | $-1.59M | $-757.91K | $-2.00M | $-3.70M | $- |
Quarterly Cash Flow Statement
| Breakdown | 2019-03-31 | 2019-06-30 | 2020-03-31 | 2020-06-30 | 2020-09-30 | 2020-12-31 | 2021-03-31 | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-663.98K | $-544.27K | $-546.87K | $-155.16K | $-189.04K | $-154.28K | $-1.41M | $-252.30K | $-639.50K | $-1.40M | $-937.95K | $-994.91K | $-925.95K | $-1.24M | $-1.72M | $-1.40M | $-1.27M | $4.39M | $-1.10M | $- |
| Depreciation and Amortization | $14.71K | $14.71K | $30.21K | $27.53K | $25.85K | $25.16K | $21.46K | $21.54K | $21.54K | $21.90K | $16.71K | $17.27K | $24.73K | $29.22K | $30.25K | $41.33K | $41.33K | $-112.91K | $41.33K | $1.25M |
| Deferred Income Tax | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $51.82K | $- | $- | $- | $- | $-57.98K | $--0.00B | $57.98K | $- | $- |
| Stock Based Compensation | $5.82K | $5.80K | $6.89K | $4.96K | $7.07K | $1.29K | $1.01K | $3.19K | $214.75K | $115.03K | $55.91K | $67.00K | $67.00K | $67.00K | $82.59K | $106.43K | $106.18K | $-295.21K | $65.65K | $- |
| Change in Working Capital | $178.44K | $-14.39K | $198.90K | $18.79K | $160.00K | $-506.19K | $222.25K | $279.62K | $-632.13K | $250.22K | $-244.42K | $-111.67K | $-99.64K | $300.34K | $275.53K | $-514.42K | $58.69K | $180.20K | $- | $- |
| Accounts Receivables | $18.05K | $-9.64K | $-14.58K | $--0.00B | $8.93K | $29.64K | $-15.32K | $15.32K | $--0.00B | $-0.00B | $1.20K | $-1.18K | $1.18K | $8.30K | $- | $- | $- | $- | $- | $- |
| Inventory | $21.43K | $-78.33K | $81.18K | $- | $- | $-0.00B | $4.51K | $-0.00B | $-10.46K | $-15.44K | $-4.38K | $-18.21K | $--0.00B | $2.04K | $165.85K | $- | $- | $-165.85K | $- | $- |
| Accounts Payables | $96.54K | $50.11K | $28.80K | $-33.44K | $14.09K | $-45.27K | $74.69K | $153.86K | $-323.22K | $104.20K | $-246.91K | $-124.05K | $83.18K | $38.86K | $263.69K | $-504.28K | $23.88K | $216.72K | $-25.50K | $- |
| Other Working Capital | $42.41K | $23.47K | $103.51K | $52.23K | $136.98K | $-981.26K | $316.75K | $220.40K | $-596.85K | $322.87K | $5.67K | $31.77K | $-183.83K | $251.14K | $-429.54K | $-10.14K | $34.82K | $404.87K | $- | $- |
| Other Non Cash Items | $- | $- | $- | $- | $- | $286.97K | $934.26K | $2.19K | $193.78K | $43.08K | $27.51K | $38.74K | $34.28K | $90.46K | $207.96K | $11.69K | $11.69K | $-231.34K | $- | $- |
| Net Cash Provided by Operating Activities | $-465.02K | $-538.16K | $-310.86K | $-103.88K | $3.88K | $-347.05K | $-235.65K | $54.24K | $-841.56K | $-966.91K | $-1.03M | $-983.57K | $-899.57K | $-749.00K | $-1.12M | $-1.81M | $-1.05M | $3.98M | $-991.04K | $- |
| Investments in Property Plant and Equipment | $- | $- | $- | $- | $- | $- | $-5.25K | $- | $- | $-9.22K | $-6.93K | $-21.84K | $--0.00B | $-10.36K | $-61.89K | $--0.00B | $--0.00B | $61.99K | $- | $- |
| Acquisitions Net | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-1.57M | $- | $1.57M | $- | $- |
| Purchases of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $--0.00B | $- | $-2.50M | $-1.51M | $- | $-2.80M | $- | $2.80M | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $5.88M | $- | $- | $5.88M | $2.55M | $4.37M | $- | $-6.92M | $- | $- |
| Other Investing Activities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-5.98M | $- | $- | $-2.50M | $-5.88M | $2.55M | $1.57M | $- | $1.83T | $- | $- |
| Net Cash Used for Investing Activities | $- | $- | $- | $- | $- | $- | $-5.25K | $- | $- | $-5.99M | $5.87M | $-21.84K | $-2.50M | $-1.52M | $2.49M | $1.57M | $--0.00B | $1.83T | $- | $- |
| Debt Repayment | $-6.50K | $- | $- | $- | $- | $-25.00K | $- | $- | $- | $-270.01K | $- | $- | $- | $- | $- | $- | $-12.94K | $-12.94K | $-14.03K | $- |
| Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $1.50M | $300.75K | $- | $-1.80M | $- | $- |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $459.00K | $- | $- | $- | $- | $372.05K | $- | $- | $- | $-68.98K | $- | $- | $- | $- | $1.50M | $-313.18K | $- | $339.07K | $- | $- |
| Net Cash Used Provided by Financing Activities | $452.50K | $541.00K | $305.00K | $110.00K | $-10.00K | $347.05K | $250.00K | $- | $12.08M | $-338.99K | $- | $- | $- | $- | $1.50M | $-12.43K | $-12.94K | $-1.47M | $-14.03K | $- |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-740.93K | $- | $740.93K | $- | $- |
| Net Change in Cash | $-12.52K | $2.84K | $-5.86K | $6.12K | $-6.12K | $- | $9.10K | $54.24K | $11.24M | $-7.29M | $4.84M | $-1.01M | $-3.40M | $-2.27M | $2.86M | $-253.98K | $-1.06M | $1.83T | $-1.01M | $- |
| Cash at End of Period | $52.18K | $55.02K | $- | $6.12K | $- | $- | $9.10K | $63.34K | $11.31M | $4.02M | $8.86M | $7.85M | $4.45M | $2.18M | $5.04M | $4.79M | $3.73M | $1.83T | $1.69M | $- |
| Cash at Beginning of Period | $64.69K | $52.18K | $5.86K | $- | $6.12K | $- | $- | $9.10K | $63.34K | $11.31M | $4.02M | $8.86M | $7.85M | $4.45M | $2.18M | $5.04M | $4.79M | $3.73M | $2.69M | $- |
| Operating Cash Flow | $-465.02K | $-538.16K | $-310.86K | $-103.88K | $3.88K | $-347.05K | $-235.65K | $54.24K | $-841.56K | $-966.91K | $-1.03M | $-983.57K | $-899.57K | $-749.00K | $-1.12M | $-1.81M | $-1.05M | $3.98M | $-991.04K | $- |
| Capital Expenditure | $- | $- | $- | $- | $- | $- | $-5.25K | $- | $- | $-9.22K | $-6.93K | $-21.84K | $--0.00B | $-10.36K | $-61.89K | $--0.00B | $--0.00B | $61.99K | $- | $- |
| Free Cash Flow | $-465.02K | $-538.16K | $-310.86K | $-103.88K | $3.88K | $-347.05K | $-240.90K | $54.24K | $-841.56K | $-976.13K | $-1.04M | $-1.01M | $-900.46K | $-759.36K | $-1.18M | $-1.81M | $-1.05M | $4.05M | $-991.04K | $- |
SeqLL Dividends
Understand SeqLL's dividend history, dividend yield, payout ratio, and more.
Dividend Yield
-
Dividend Payout Ratio
-
Dividend Paid & Capex Coverage Ratio
0.00x
SeqLL Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|
Valuation
Analyze the market cap, enterprise value, and valuation metrics for SeqLL.
Market Cap & Enterprise Value
Market Cap: $185.31M
Enterprise Value: $-1.14T
Valuation Ratios
P/E Ratio: 0.00
P/B Ratio: 0.00
P/CF Ratio: 0.00
Valuation Multiples
E/V to Sales: 0.00
E/V to EBITDA: 0.00
Market Cap & Enterprise Value
Market capitalization and enterprise value provide an understanding of a company's market value and total value, respectively.
- Market Cap: The total market value of a company's outstanding shares of stock. It represents the company's equity value and is calculated by multiplying the current share price by the total number of outstanding shares.
- Enterprise Value (EV): A measure of a company's total value, often seen as a more comprehensive alternative to equity market capitalization. It includes market cap plus debt, minority interest, and preferred shares, minus total cash and cash equivalents.
Valuation Ratios
Valuation ratios are used to evaluate the value of a company compared to its earnings, book value, and cash flow.
- P/E Ratio: Price to Earnings Ratio, indicating how much investors are willing to pay for a dollar of earnings.
- P/B Ratio: Price to Book Ratio, comparing the company's market value to its book value. A lower ratio may indicate undervaluation.
- P/CF Ratio: Price to Cash Flow Ratio, evaluating the market value relative to the operating cash flow. A lower ratio can signal a more attractive investment.
Valuation Multiples
Valuation multiples help assess a company's value relative to its revenue and earnings.
- EV to Sales: Enterprise Value to Sales, comparing the enterprise value to sales revenue. A lower ratio can indicate a more attractive investment.
- EV to EBITDA: Enterprise Value to EBITDA, comparing the enterprise value to earnings before interest, taxes, depreciation, and amortization. A lower ratio suggests a company may be undervalued.
SeqLL Growth
View income_statement_chart2_annual_data financial growth metrics for SeqLL, including income statement, balance sheet, and cash flow growth.
Income Growth
Revenue Growth: 0.00%
Operating Income Growth: -658.74%
Cash Flow Growth
Net Income Growth: 100.00%
Free Cash Flow Growth: 100.00%
Balance Sheet Growth
Total Assets Growth: 3899.74%
Total Liabilities Growth: 2843.98%
Income Growth
This section highlights key metrics related to income growth, showing how the company’s revenue and operating income have changed over time:
- Revenue Growth: The increase in a company's sales over time. It is a measure of how quickly the company is growing its revenue. This chart shows the historical trend of revenue growth.
- Operating Income Growth: The growth rate of a company's operating income, which is the income earned from its normal business operations. This chart helps to assess the company's operational efficiency and profitability growth over time.
Cash Flow Growth
This section highlights key metrics on the company's cash flow growth, reflecting changes in net income and free cash flow over time.
- Net Income Growth: The increase in a company's net profit over time. It reflects the company's ability to increase its profitability. This chart provides insight into how the company's bottom line has grown.
- Free Cash Flow Growth: The growth in a company's free cash flow, which is the cash generated by the company after accounting for capital expenditures. This chart is important for understanding the company's financial flexibility and ability to fund operations and growth.
Balance Sheet Growth
This section highlight key metrics related to balance sheet growth, which indicate how the company’s total assets and liabilities have changed over time:
- Total Assets Growth: The rate at which a company's total assets are increasing over time. This chart indicates how the company's asset base is expanding, which can be a sign of growth and investment in future operations.
- Total Liabilities Growth: The rate at which a company's total liabilities are increasing over time. This chart helps to assess the company's financial leverage and risk over time.
Peers: Medical - Diagnostics & Research
This section provides companies within the same sector, on the same exchange, and of similar market capitalization, allowing comparisons of key financial indicators among peers.
| Company | Market Cap | Price | EPS | P/E Ratio | P/B Ratio |
|---|---|---|---|---|---|
|
$- | $ | $ | $ | $ |
Biocept, Inc.
BIOC
|
$- | $0.43 | $-56.78 | $-0.28 | $1.01 |
HTG Molecular Diagnostics, Inc.
HTGM
|
$1.06M | $0.48 | $-24.28 | $-0.16 | $0.66 |
Agilent Technologies, Inc.
A
|
$41.65B | $144.97 | $4.22 | $24.51 | $5.20 |
Genetic Technologies Limited
GENE
|
$6.94M | $0.73 | $-0.10 | $-21.22 | $139.33 |
T2 Biosystems, Inc.
TTOO
|
$31.81M | $1.82 | $-19.19 | $-0.33 | $-0.58 |
iSpecimen Inc.
ISPC
|
$3.42M | $5.23 | $-1.23 | $-8.15 | $9.29 |
Interpace Biosciences, Inc.
IDXG
|
$8.83M | $2.01 | $0.19 | $5.81 | $-0.31 |
Intelligent Bio Solutions Inc.
INBS
|
$6.76M | $1.59 | $-6.39 | $-0.29 | $0.35 |
bioAffinity Technologies, Inc.
BIAF
|
$24.55M | $1.82 | $-0.91 | $-1.62 | $2.65 |
More metrics for SeqLL
Access more key metrics, financials, ratios, and more with the links below.